ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration …
Over the last 12 months, insiders at ClearPoint Neuro, Inc. have bought $0 and sold $0 worth of ClearPoint Neuro, Inc. stock.
On average, over the past 5 years, insiders at ClearPoint Neuro, Inc. have bought $0 and sold $554,758 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 25,000 shares for transaction amount of $31,250 was made by BURNETT JOSEPH MICHAEL (President and CEO) on 2018‑09‑25.
2022-08-15 | Sale | CEO and President | 18,867 0.0889% | $16.07 | $303,193 | -43.20% | ||
2021-11-11 | Sale | CEO and President | 10,000 0.0495% | $16.88 | $168,800 | -36.25% | ||
2021-09-21 | Sale | CEO and President | 9,637 0.0508% | $17.98 | $173,273 | -37.50% | ||
2021-06-21 | Sale | CEO and President | 25,000 0.1361% | $18.57 | $464,250 | -37.48% | ||
2018-09-25 | President and CEO | 25,000 0.0092% | $1.25 | $31,250 | +74.16% | |||
2018-08-24 | President and CEO | 7,500 0.0035% | $1.58 | $11,850 | +87.01% | |||
2018-08-22 | President and CEO | 4,637 0.0021% | $1.55 | $7,187 | +78.13% | |||
2018-05-21 | President and CEO | 7,500 0.0052% | $2.39 | $17,903 | -12.50% | |||
2017-05-26 | CHIEF EXECUTIVE OFFICER | 12,500 0.0073% | $2.00 | $25,000 | -14.06% | |||
2017-05-26 | director | 7,500 0.0044% | $2.00 | $15,000 | -14.06% | |||
2016-09-02 | CHIEF EXECUTIVE OFFICER | 20,000 0.0293% | $5.00 | $100,000 | -39.86% | |||
2016-09-02 | director | 10,000 0.0147% | $5.00 | $50,000 | -39.86% | |||
2015-12-18 | director | 154,035 0.0147% | $0.32 | $50,000 | -42.50% | |||
2015-12-18 | director | 154,035 0.0147% | $0.32 | $50,000 | -42.50% | |||
2015-12-18 | CHIEF EXECUTIVE OFFICER/PRES | 308,071 0.0293% | $0.32 | $100,000 | -42.50% | |||
2015-12-18 | director | 77,017 0.0073% | $0.32 | $25,000 | -42.50% | |||
2014-12-24 | director | 23,310 0.0044% | $0.64 | $15,000 | -8.79% | |||
2014-09-12 | director | 16,000 0.0055% | $1.18 | $18,880 | -11.61% | |||
2014-08-13 | director | 3,500 0.001% | $1.00 | $3,500 | 0.00% | |||
2014-06-13 | 30,000 0.0064% | $0.73 | $21,900 | +36.99% |
KOOB CHARLES E | director | 736931 2.6715% | $15.71 | 1 | 0 | |
PIETRANGELO MICHAEL | director | 451296 1.636% | $15.71 | 7 | 0 | +2.54% |
Malernee James K. Jr. | director | 290659 1.0537% | $15.71 | 2 | 0 | <0.0001% |
BURNETT JOSEPH MICHAEL | CEO and President | 262095 0.9501% | $15.71 | 4 | 4 | +56.7% |
Richards Timothy T. | director | 110005 0.3988% | $15.71 | 1 | 0 |